Status:
ACTIVE_NOT_RECRUITING
Ageing BIOmarker Study in Singaporeans
Lead Sponsor:
National University of Singapore
Conditions:
Healthy Aging
Biological Aging
Eligibility:
All Genders
21+ years
Brief Summary
The Ageing BIOmarker Study in Singaporeans (ABIOS) aims to understand the biological aging processes and how they affect health among people in Singapore. As people grow older, their risk of developin...
Detailed Description
Biological ageing is the primary driver of age-associated chronic diseases in older adults. Asian populations have been underrepresented in studies developing biological age predictors and understandi...
Eligibility Criteria
Inclusion
- ≥21 years of age
- Chinese, Malay, or Indian and has lived in Singapore for at least 5 consecutive years
- Apparently healthy and non-smokers
- Having only 1 condition (if ≥45 and \<65 years) or any condition (if ≥65 years), and all conditions were medication-controlled (if any):
- Hypertension
- Hyperlipidemia
- Hyperglycemia
- Osteopenia/osteoporosis
- Osteoarthritis
- Type 2 diabetes
Exclusion
- Body mass index (BMI) ≥30 kg/m\^2
- Pre-existing or history of major cardiovascular disease (e.g., coronary artery disease, heart failure, stroke, peripheral vascular disease)
- Any metal implants (excluding dental implants) in the body
- Pre-existing or history of cancer or chronic obstructive pulmonary disease (COPD)
- Pregnant women or planning pregnancy in the next 6-12 months
Key Trial Info
Start Date :
March 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT06555978
Start Date
March 12 2021
End Date
August 31 2025
Last Update
October 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Healthy Longevity at Alexandra Hospital
Singapore, Singapore, 159964